Research uncovers key therapeutic target for reversing accelerated atherosclerosis in diabetes

Diabetes accelerates the development of atherosclerosis, increasing the incidence of cardiovascular events.

Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™ – Biotech Investments

Marizyme, Inc. Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™ 06-Oct-2023 / 15:00 CET/CEST The issuer is solely responsible for the content of this

October 7, 2023

FDA Approves First Drug for Rare Lipid Storage Disorder

The FDA on Friday approved chenodiol (Ctexli) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Chenodiol — a naturally occurring human bile acid also

February 22, 2025

Health Plans Have an Engagement Problem. Providers of Care Can Help

Anish Sebastian, CEO and Co-founder, Babyscripts A health plan’s success rests on many factors: improving health outcomes, controlling costs, optimizing risk adjustment, and encouraging member

August 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.